首页> 美国卫生研究院文献>PLoS Clinical Trials >Cloning, Expression and Characterization of a Gene from Earthworm Eisenia fetida Encoding a Blood-Clot Dissolving Protein
【2h】

Cloning, Expression and Characterization of a Gene from Earthworm Eisenia fetida Encoding a Blood-Clot Dissolving Protein

机译:f血腥ise编码血凝蛋白的基因的克隆,表达与鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

A lumbrokinase gene encoding a blood-clot dissolving protein was cloned from earthworm (Eisenia fetida) by RT-PCR amplification. The gene designated as CST1 (GenBank No. ) was sequence analyzed. The cDNA consists of 888 bp with an open reading frame of 729 bp, which encodes 242 amino acid residues. Multiple sequence alignments revealed that CST1 shares similarities and conserved amino acids with other reported lumbrokinases. The amino acid sequence of CST1 exhibits structural features similar to those found in other serine proteases, including human tissue-type (tPA), urokinase (uPA), and vampire bat (DSPAα1) plasminogen activators. CST1 has a conserved catalytic triad, found in the active sites of protease enzymes, which are important residues involved in polypeptide catalysis. CST1 was expressed as inclusion bodies in Escherichia coli BL21(DE3). The molecular mass of recombinant CST1 (rCST) was 25 kDa as estimated by SDS–PAGE, and further confirmed by Western Blot analysis. His-tagged rCST1 was purified and renatured using nickel-chelating resin with a recovery rate of 50% and a purity of 95%. The purified, renatured rCST1 showed fibrinolytic activity evaluated by both a fibrin plate and a blood clot lysis assay. rCST1 degraded fibrin on the fibrin plate. A significant percentage (65.7%) of blood clot lysis was observed when blood clot was treated with 80 mg/mL of rCST1 in vitro. The antithrombotic activity of rCST1 was 912 units/mg calculated by comparison with the activity of a lumbrokinase standard. These findings indicate that rCST1 has potential as a potent blood-clot treatment. Therefore, the expression and purification of a single lumbrokinase represents an important improvement in the use of lumbrokinases.
机译:通过RT-PCR扩增,从((Eisenia fetida)克隆了编码血凝块溶解蛋白的gene激酶基因。序列分析指定为CST1的基因(GenBank No.)。 cDNA由888 bp组成,其开放阅读框为729 bp,编码242个氨基酸残基。多个序列比对揭示,CST1与其他报道的激酶具有相似性和保守氨基酸。 CST1的氨基酸序列具有与其他丝氨酸蛋白酶类似的结构特征,包括人体组织型(tPA),尿激酶(uPA)和吸血蝙蝠(DSPAα1)纤溶酶原激活剂。 CST1具有保守的催化三联体,存在于蛋白酶的活性位点中,蛋白酶的活性位点是参与多肽催化的重要残基。 CST1在大肠杆菌BL21(DE3)中表达为包涵体。通过SDS-PAGE估算,重组CST1(rCST)的分子量为25 kDa,并通过Western Blot分析进一步证实。使用镍螯合树脂纯化和标记带有His标签的rCST1,使其具有50%的回收率和95%的纯度。纯化,复性的rCST1通过纤维蛋白板和血凝块溶解试验评估显示出纤溶活性。 rCST1降解了血纤蛋白板上的血纤蛋白。当用80 mg / mL的rCST1体外处理血凝块时,观察到显着百分比(65.7%)的血凝块溶解。与C激酶标准品的活性比较,rCST1的抗血栓形成活性为912单位/ mg。这些发现表明,rCST1具有作为强力血栓治疗的潜力。因此,单一激酶的表达和纯化代表了lum激酶使用中的重要改进。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号